By Dawn Kopecki, Jarrett Renshaw, Ernest Scheyder and Sabrina Valle NEW YORK, October 2 (Reuters) -Eli Lilly was asked to ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

European and U.S. healthcare stocks surged on Wednesday, propelled by a deal between Pfizer and President Donald Trump to ...

While companies have been able to eat some higher costs from tariffs enacted earlier this year, that flexibility has limits, ...

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...

AstraZeneca saw its share prices jump to a new all-time high on Wednesday, as investors cheered reports that President Donald ...

AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration ...

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new ...

In today's Pharmalittle roundup, we're reading about delayed pharma tariffs, how the government shutdown affects FDA, and ...

This story was originally published by Grist with the headline In Arizona, a fight against a deadly fungus is under threat ...

With thousands of RSV-related hospitalisations in at-risk groups annually in the US, the need for novel antivirals is ...

The FTSE 100 hit another record high on Wednesday, despite concerns over the US shutdown, as pharmaceutical stocks powered ...